1 Min Read
July 17 (Reuters) - Fortress Biotech Inc:
* Fortress Biotech announces filing of provisional patent application for Caelum Biosciences’ cael-101 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.